We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TRML Tourmaline Bio Inc

0.25 (1.33%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 28,712
Bid Price 12.19
Ask Price 26.55
News -
Day High 19.5626


52 Week Range


Day Low 17.95
Company Name Stock Ticker Symbol Market Type
Tourmaline Bio Inc TRML NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.25 1.33% 19.00 18:00:02
Open Price Low Price High Price Close Price Prev Close
19.03 17.95 19.5626 19.00 18.75
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,420 28,712 $ 18.82 $ 540,378 - 9.18 - 20.00
Last Trade Time Type Quantity Stock Price Currency
17:21:26 2 $ 19.88 USD

Tourmaline Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
385.99M 20.34M - 0 -73.89M -3.63 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Tourmaline Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TRML Message Board. Create One! See More Posts on TRML Message Board See More Message Board Posts

Historical TRML Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.0020.0017.1818.7855,0991.005.56%
1 Month17.8020.0013.8117.2151,3321.206.74%
3 Months10.3220.009.1815.0567,6668.6884.11%
6 Months10.3220.009.1815.0567,6668.6884.11%
1 Year10.3220.009.1815.0567,6668.6884.11%
3 Years10.3220.009.1815.0567,6668.6884.11%
5 Years10.3220.009.1815.0567,6668.6884.11%

Tourmaline Bio Description

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |